Why multivalency shifts apparent affinity
Multivalent ligands can bind more strongly than a single site predicts because multiple contacts reduce dissociation. With n=4 and c=1, raising L from 0.1 to 1.0 µM can move θ from about 0.08 to about 0.33 in the example table, while P(at least one) rises toward 0.80. The partition sum Z captures how small changes in activity a can amplify occupancy when several bonds are possible.
Interpreting valency n and site saturation θ
Valency n sets the maximum number of simultaneous bonds. The calculator reports ⟨i⟩ and θ=⟨i⟩/n so you can compare designs with different n. If ⟨i⟩=2.40 at n=6, then θ=0.40, meaning 40% of sites are occupied on average. When n increases at fixed Kd and L, the distribution P(i) broadens and P(0) can drop quickly even if θ stays moderate.
Using cooperativity c to represent clustering
Cooperativity c adjusts how additional bonds are favored once one bond forms. The weight term c^{i(i−1)/2} applies to every bound pair, so c=2 increases preference per pair and steepens the binding curve. In the example with n=6, Kd=0.2 µM, L=0.2 µM, c=2 and E=3, θ is near 0.75 and P(at least one) approaches 0.99, consistent with clustering.
Avidity enhancement E and effective concentration
E scales L into an effective concentration L_eff=E·L to mimic proximity, tethering, or surface confinement. For surface-presented ligands, E values between 2 and 10 are often used as a coarse screen when geometries are unknown. Because a=L_eff/Kd, doubling E has the same effect as doubling L or halving Kd. The results panel shows L_eff so you can sanity-check whether the implied local concentration is realistic.
Export-ready tables for screening and reporting
The curve table generates 5–200 points on linear or logarithmic spacing, useful for screening across decades of concentration. Export the curve CSV for plotting in spreadsheets, or export PDFs for lab notes and review packets. A practical workflow is to hold Kd fixed, sweep E and c, and compare L_0.5 and the local Hill slope to prioritize constructs that reach high P(at least one) at feasible dosing ranges. For early-stage design choices.